SE501169C2 - Framställning av serumalbuminbindande fusionsproteiner vilka innehåller protein G-domäner - Google Patents

Framställning av serumalbuminbindande fusionsproteiner vilka innehåller protein G-domäner

Info

Publication number: SE501169C2
Authority: SE; Sweden
Prior art keywords: polypeptide; protein; fusion protein; dna sequence; recombinant vector
Prior art date: 1988-02-05

Application number

SE8800378A

Other languages

English (en)

Swedish (sv)

Other versions

SE8800378D0 (sv

SE8800378L (sv

Inventor

Per-Aake Nygren

Lars Abrahmsen

Mathias Uhlen

Original Assignee

Aake Nygren

Lars Abrahmsen

Mathias Uhlen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-02-05

Filing date

1988-02-05

Publication date

1994-11-28

1988-02-05 Application filed by Aake Nygren, Lars Abrahmsen, Mathias Uhlen filed Critical Aake Nygren

1988-02-05 Priority to SE8800378A priority Critical patent/SE501169C2/sv

1988-02-05 Publication of SE8800378D0 publication Critical patent/SE8800378D0/xx

1989-02-02 Priority to ES89850031T priority patent/ES2080759T3/es

1989-02-02 Priority to DE68925044T priority patent/DE68925044T2/de

1989-02-02 Priority to AT89850031T priority patent/ATE131494T1/de

1989-02-02 Priority to EP89850031A priority patent/EP0327522B1/de

1989-02-03 Priority to JP1024142A priority patent/JP3026812B2/ja

1989-08-06 Publication of SE8800378L publication Critical patent/SE8800378L/

1994-11-28 Publication of SE501169C2 publication Critical patent/SE501169C2/sv

1996-01-09 Priority to GR960400037T priority patent/GR3018617T3/el

Links

230000027455 binding Effects 0.000 title claims abstract description 43
102000037865 fusion proteins Human genes 0.000 title claims abstract description 30
108020001507 fusion proteins Proteins 0.000 title claims abstract description 30
102000007562 Serum Albumin Human genes 0.000 title claims abstract 8
108010071390 Serum Albumin Proteins 0.000 title claims abstract 8
101710120037 Toxin CcdB Proteins 0.000 title claims description 15
108090000623 proteins and genes Proteins 0.000 claims abstract description 77
102000004169 proteins and genes Human genes 0.000 claims abstract description 54
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 48
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 45
229920001184 polypeptide Polymers 0.000 claims abstract description 44
239000013598 vector Substances 0.000 claims abstract description 30
238000000034 method Methods 0.000 claims abstract description 26
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 24
239000012634 fragment Substances 0.000 claims abstract description 23
239000001963 growth medium Substances 0.000 claims abstract description 6
238000012258 culturing Methods 0.000 claims abstract description 5
230000001131 transforming effect Effects 0.000 claims abstract description 5
244000005700 microbiome Species 0.000 claims abstract 2
108010088751 Albumins Proteins 0.000 claims description 27
102000009027 Albumins Human genes 0.000 claims description 27
238000003795 desorption Methods 0.000 claims description 8
239000012876 carrier material Substances 0.000 claims description 5
108020004414 DNA Proteins 0.000 claims description 4
230000001580 bacterial effect Effects 0.000 claims description 4
238000001179 sorption measurement Methods 0.000 claims description 4
108010076504 Protein Sorting Signals Proteins 0.000 claims description 3
238000002955 isolation Methods 0.000 claims description 3
241000193830 Bacillus <bacterium> Species 0.000 claims description 2
241000588722 Escherichia Species 0.000 claims description 2
241000191940 Staphylococcus Species 0.000 claims description 2
241000194017 Streptococcus Species 0.000 claims 1
101710172711 Structural protein Proteins 0.000 claims 1
230000003362 replicative effect Effects 0.000 claims 1
230000010076 replication Effects 0.000 abstract 1
239000013612 plasmid Substances 0.000 description 22
230000004927 fusion Effects 0.000 description 21
210000004027 cell Anatomy 0.000 description 18
239000000047 product Substances 0.000 description 18
241000588724 Escherichia coli Species 0.000 description 14
102000004190 Enzymes Human genes 0.000 description 12
108090000790 Enzymes Proteins 0.000 description 12
229940088598 enzyme Drugs 0.000 description 12
230000000694 effects Effects 0.000 description 10
239000002609 medium Substances 0.000 description 10
239000000463 material Substances 0.000 description 8
108020004511 Recombinant DNA Proteins 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
102000036639 antigens Human genes 0.000 description 7
108091007433 antigens Proteins 0.000 description 7
238000003776 cleavage reaction Methods 0.000 description 7
230000003204 osmotic effect Effects 0.000 description 7
230000007017 scission Effects 0.000 description 7
230000035939 shock Effects 0.000 description 7
239000000427 antigen Substances 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
108020004774 Alkaline Phosphatase Proteins 0.000 description 5
239000000872 buffer Substances 0.000 description 5
238000000746 purification Methods 0.000 description 5
102000002260 Alkaline Phosphatase Human genes 0.000 description 4
102000053602 DNA Human genes 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
238000001042 affinity chromatography Methods 0.000 description 4
150000001413 amino acids Chemical group 0.000 description 4
229960000723 ampicillin Drugs 0.000 description 4
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
238000010367 cloning Methods 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
239000000499 gel Substances 0.000 description 4
238000001502 gel electrophoresis Methods 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
235000015097 nutrients Nutrition 0.000 description 4
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
239000001974 tryptic soy broth Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
238000002835 absorbance Methods 0.000 description 3
230000008901 benefit Effects 0.000 description 3
102000023732 binding proteins Human genes 0.000 description 3
108091008324 binding proteins Proteins 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
230000008859 change Effects 0.000 description 3
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 3
230000029087 digestion Effects 0.000 description 3
238000005342 ion exchange Methods 0.000 description 3
239000013600 plasmid vector Substances 0.000 description 3
239000013014 purified material Substances 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
230000009466 transformation Effects 0.000 description 3
238000013519 translation Methods 0.000 description 3
102100023995 Beta-nerve growth factor Human genes 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
108010025020 Nerve Growth Factor Proteins 0.000 description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
229920002684 Sepharose Polymers 0.000 description 2
102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
239000003463 adsorbent Substances 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000010276 construction Methods 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
238000010828 elution Methods 0.000 description 2
238000002523 gelfiltration Methods 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
230000003100 immobilizing effect Effects 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
239000012160 loading buffer Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
229940053128 nerve growth factor Drugs 0.000 description 2
210000001322 periplasm Anatomy 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
229960000187 tissue plasminogen activator Drugs 0.000 description 2
VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
UKGGPJNBONZZCM-WDSKDSINSA-N Asp-Pro Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O UKGGPJNBONZZCM-WDSKDSINSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
108090000746 Chymosin Proteins 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
108010013369 Enteropeptidase Proteins 0.000 description 1
102100029727 Enteropeptidase Human genes 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
108050001049 Extracellular proteins Proteins 0.000 description 1
108010074860 Factor Xa Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
101000636168 Grapevine leafroll-associated virus 3 (isolate United States/NY1) Movement protein p5 Proteins 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
206010062717 Increased upper airway secretion Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
239000007836 KH2PO4 Substances 0.000 description 1
108060005987 Kallikrein Proteins 0.000 description 1
102000001399 Kallikrein Human genes 0.000 description 1
HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
108090000189 Neuropeptides Proteins 0.000 description 1
102000003797 Neuropeptides Human genes 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
239000004365 Protease Substances 0.000 description 1
101100373202 Rattus norvegicus Cx3cl1 gene Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
206010039424 Salivary hypersecretion Diseases 0.000 description 1
102000013275 Somatomedins Human genes 0.000 description 1
108010088160 Staphylococcal Protein A Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
108010093581 aspartyl-proline Proteins 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
230000003196 chaotropic effect Effects 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
238000012412 chemical coupling Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
229940080701 chymosin Drugs 0.000 description 1
239000004927 clay Substances 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000012050 conventional carrier Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
239000003446 ligand Substances 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
235000019796 monopotassium phosphate Nutrition 0.000 description 1
GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
208000026435 phlegm Diseases 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
208000026451 salivation Diseases 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000012216 screening Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
108010050327 trypticase-soy broth Proteins 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Tropical Medicine & Parasitology (AREA)
General Engineering & Computer Science (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SE8800378A 1988-02-05 1988-02-05 Framställning av serumalbuminbindande fusionsproteiner vilka innehåller protein G-domäner SE501169C2 (sv)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
SE8800378A SE501169C2 (sv)	1988-02-05	1988-02-05	Framställning av serumalbuminbindande fusionsproteiner vilka innehåller protein G-domäner
ES89850031T ES2080759T3 (es)	1988-02-05	1989-02-02	Produccion de proteinas o polipeptidos fusionados.
DE68925044T DE68925044T2 (de)	1988-02-05	1989-02-02	Herstellung von Fusionsproteinen oder -polypeptiden
AT89850031T ATE131494T1 (de)	1988-02-05	1989-02-02	Herstellung von fusionsproteinen oder - polypeptiden
EP89850031A EP0327522B1 (de)	1988-02-05	1989-02-02	Herstellung von Fusionsproteinen oder -polypeptiden
JP1024142A JP3026812B2 (ja)	1988-02-05	1989-02-03	融合タンパク質またはポリペプチドの生産
GR960400037T GR3018617T3 (en)	1988-02-05	1996-01-09	Production of fused proteins or polypeptides

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE8800378A SE501169C2 (sv)	1988-02-05	1988-02-05	Framställning av serumalbuminbindande fusionsproteiner vilka innehåller protein G-domäner

Publications (3)

Publication Number	Publication Date
SE8800378D0 SE8800378D0 (sv)	1988-02-05
SE8800378L SE8800378L (sv)	1989-08-06
SE501169C2 true SE501169C2 (sv)	1994-11-28

Family

ID=20371279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8800378A SE501169C2 (sv)	1988-02-05	1988-02-05	Framställning av serumalbuminbindande fusionsproteiner vilka innehåller protein G-domäner

Country Status (7)

Country	Link
EP (1)	EP0327522B1 (de)
JP (1)	JP3026812B2 (de)
AT (1)	ATE131494T1 (de)
DE (1)	DE68925044T2 (de)
ES (1)	ES2080759T3 (de)
GR (1)	GR3018617T3 (de)
SE (1)	SE501169C2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1991011454A1 (en) *	1990-01-24	1991-08-08	The Upjohn Company	Method of purifying recombinant polypeptides
US5595887A (en) *	1990-07-16	1997-01-21	Bionebraska, Inc.	Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
DE4037837A1 (de) *	1990-11-28	1992-06-04	Behringwerke Ag	Zellfreie rezeptorbindungsteste, ihre herstellung und verwendung
FR2726471B1 (fr) *	1994-11-07	1997-01-31	Pf Medicament	Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
GB9509336D0 (en) *	1995-05-09	1995-06-28	Dynal As	Chemical method
GB9716790D0 (en)	1997-08-07	1997-10-15	Creative Peptides Sweden Ab	Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof
EP1900754A1 (de) *	2006-09-18	2008-03-19	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Fusionsprotein enthaltend zwei IgG bindende Domänen des G Proteins von Streptococcus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8300693L (sv) *	1983-02-09	1984-08-10	Sven Lofdahl	Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
SE459662B (sv) *	1986-03-21	1989-07-24	Pharmacia Ab	Hybrid-dna-molekyl som kodar foer ett protein med samma igg specificitet som protein g, plasmid innehaallande densamma samt foerfarande foer framstaellning av proteinet

1988
- 1988-02-05 SE SE8800378A patent/SE501169C2/sv not_active IP Right Cessation
1989
- 1989-02-02 DE DE68925044T patent/DE68925044T2/de not_active Expired - Fee Related
- 1989-02-02 ES ES89850031T patent/ES2080759T3/es not_active Expired - Lifetime
- 1989-02-02 EP EP89850031A patent/EP0327522B1/de not_active Expired - Lifetime
- 1989-02-02 AT AT89850031T patent/ATE131494T1/de not_active IP Right Cessation
- 1989-02-03 JP JP1024142A patent/JP3026812B2/ja not_active Expired - Fee Related
1996
- 1996-01-09 GR GR960400037T patent/GR3018617T3/el unknown

Also Published As

Publication number	Publication date
GR3018617T3 (en)	1996-04-30
EP0327522A3 (en)	1990-07-04
JPH025887A (ja)	1990-01-10
ATE131494T1 (de)	1995-12-15
SE8800378D0 (sv)	1988-02-05
DE68925044T2 (de)	1996-05-09
DE68925044D1 (de)	1996-01-25
EP0327522A2 (de)	1989-08-09
EP0327522B1 (de)	1995-12-13
JP3026812B2 (ja)	2000-03-27
ES2080759T3 (es)	1996-02-16
SE8800378L (sv)	1989-08-06

Legal Events

Date	Code	Title	Description
2004-09-28	NUG	Patent has lapsed

Publication	Publication Date	Title
EP0135532B1 (de)	1988-08-10	Herstellungsverfahren und selektive isolierung von proteinen und polypeptiden, rekombinant und expressionsvektor dazu und schmelzprotein das zum konstanten teil von immoglobulinen binden kann
US5643758A (en)	1997-07-01	Production and purification of a protein fused to a binding protein
US4349629A (en)	1982-09-14	Plasmid vectors, production anduse thereof
EP0230869B1 (de)	1992-09-02	Herstellung eines IgG-bindenden Proteins zum Erleichtern der Weiterverarbeitung mittels "Protein-engineering"
US5506121A (en)	1996-04-09	Fusion peptides with binding activity for streptavidin
JP2703770B2 (ja)	1998-01-26	結合タンパク質に融合されたタンパク質の生産及びその精製
EP0848756B1 (de)	2004-06-30	Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
JPS6019493A (ja)	1985-01-31	組換え体プラスミド，形質転換体微生物，ポリデオキシリボヌクレオチド断片，生物学的に活性な蛋白質およびその製法
EP0546049B1 (de)	1995-07-19	Eine methode für die schnelle selektion von effizienten sekretionsvektoren
EP0327522B1 (de)	1995-12-13	Herstellung von Fusionsproteinen oder -polypeptiden
JP2504723B2 (ja)	1996-06-05	組換体ｄｎａとこれを含むプラスミドベクタ―とこのような組換体ｄｎａを保持する大腸菌
US20120009624A1 (en)	2012-01-12	Protein particles
EP0243333A2 (de)	1987-10-28	Herstellung von Fusionsproteinen, Antikörper und Verfahren dazu
EP0333691A2 (de)	1989-09-20	Rekombinantes Fusionsprotein, seine Verwendung und rekombinanter Vektor
JP2688174B2 (ja)	1997-12-08	ストレプトミセスＳｔｒｅｐｔｏｍｙｃｅｓからの生物活性ヒト顆粒球マクロフアージコロニー刺激因子（ＧＭ−ＣＳＦ）及びその他の異種蛋白質の分泌に関する発現系
US20040138413A1 (en)	2004-07-15	Compositions and methods for immunoaffinity purification